Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-019646

Chief Financial Officer sold 10,000 shares at an average $147.30 ($1,472,954)

  • Chief Financial Officer acquired 19,583 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-08 Exercise or conversion : show line 1 in the form +10,000 $5.04 $50,400 30,774 D
2021-03-08 Sale : show line 2 in the form −1,022 $141.25 $144,357 29,752 D
2021-03-08 Sale : show line 3 in the form −400 $142.49 $56,994 29,352 D
2021-03-08 Sale : show line 4 in the form −1,100 $145.03 $159,528 28,252 D
2021-03-08 Sale : show line 5 in the form −1,902 $145.90 $277,501 26,350 D
2021-03-08 Sale : show line 6 in the form −1,476 $146.88 $216,793 24,874 D
2021-03-08 Sale : show line 7 in the form −200 $148.08 $29,616 24,674 D
2021-03-08 Sale : show line 8 in the form −1,100 $149.43 $164,371 23,574 D
Open-market sales · 10,000 sh · avg $147.30 · $1,472,954

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-08 Exercise or conversion : show line 15 in the form Stock Option (right to buy) −10,000 $5.04 2028-11-02 10,000 450,159 D
2021-03-10 Exercise or conversion : show line 16 in the form Stock Option (right to buy) −9,583 $11.48 2029-05-10 9,583 10,417 D
Loading xslF345X03/doc4.xml…